Elsevier

Annals of Oncology

Volume 29, Supplement 8, October 2018, Pages viii714-viii715
Annals of Oncology

Late-breaking and deferred publication abstracts
Gastrointestinal tumours, colorectal
LBA19 - Fluoropyrimidine (FP) + bevacizumab (BEV) + atezolizumab vs FP/BEV in BRAFwt metastatic colorectal cancer (mCRC): Findings from Cohort 2 of MODUL – a multicentre, randomized trial of biomarker-driven maintenance treatment following first-line induction therapy

https://doi.org/10.1093/annonc/mdy424.020Get rights and content
Under an Elsevier user license
open archive

Cited by (0)